SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001193125-15-166651
Filing Date
2015-05-01
Accepted
2015-05-01 17:19:36
Documents
7
Effectiveness Date
2015-05-01

Document Format Files

Seq Description Document Type Size
1 DEFR14A d895817ddefr14a.htm DEFR14A 100130
2 GRAPHIC g895817dsp_031c.jpg GRAPHIC 11722
3 GRAPHIC g895817dsp_060a.jpg GRAPHIC 10575
4 GRAPHIC g895817dsp_060b.jpg GRAPHIC 12793
5 GRAPHIC g895817dsp_060c.jpg GRAPHIC 9305
6 GRAPHIC g895817dsp_060d.jpg GRAPHIC 10200
7 GRAPHIC g895817dsp_061.jpg GRAPHIC 10384
  Complete submission text file 0001193125-15-166651.txt   191587
Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472
Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-36281 | Film No.: 15825573
SIC: 2834 Pharmaceutical Preparations